The FDA has granted approval to Amphastar?s generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an arrangement with Amphastar. In July the FDA approved the first generic version of enoxaparin, manufactured by Sandoz and marketed in the US by Momenta, after a ...